Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC.CSBR · Entity 7013 | Director | November 05, 2025 | November 07, 2025 |
| DAVITA INC.DVA · Entity 3482 | CFO and Treasurer | May 07, 2026 | May 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHAMPIONS ONCOLOGY, INC.
Report date November 05, 2025 · Filed November 07, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $6.80 · Expires 2035-11-05 | Direct | 21,216 |
Reported balance
After 2025-11-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-05 · Grant · Acquired 21,216 · Balance 21,216 F1: The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively.
DAVITA INC.
Report date May 07, 2026 · Filed May 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 132,434 |
Reported balance
After 2026-05-07 transaction · row 1
1 source rowRow 1 · 2026-05-07 · Sale · Disposed 51,471 · Balance 132,434 F1: Represents the weighted average sale price of $192.099. The range of prices for the sale of these shares was $191.510 - $192.765 rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the weighted average sale price of $192.099. The range of prices for the sale of these shares was $191.510 - $192.765 rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
KINDRED HEALTHCARE, INC
Report date July 02, 2018 · Filed July 02, 2018
Section 16 reporting ended · disclosed 2018-07-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-07-02 transaction · row 1
1 source rowRow 1 · 2018-07-02 · Disposition to issuer · Disposed 75,167 · Balance 0 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 07, 2026 Filed May 11, 2026 20:05 UTC | DAVITA INC. DVA · Entity 3482 | SaleCommon Stock | 51,471 | $192.10 | $9,887,527.63 |
DisclosureSEC source: 0000927066-26-000065 · wk-form4_1778529957.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,434 F1 · price: Represents the weighted average sale price of $192.099. The range of prices for the sale of these shares was $191.510 - $192.765 rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:09 UTC | DAVITA INC. DVA · Entity 3482 | GrantStock Appreciation Rights · Derivative | 15,427 | $0.00 Strike: $150.72 | $0.00 |
DisclosureSEC source: 0000927066-26-000038 · wk-form4_1773778159.xml · derivative · entry 5 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,427 Underlying: Common Stock · 15,427 shares Expires 2031-03-15 F5 · derivative.exercise_date: The stock appreciation rights are scheduled to vest 50% each on March 15, 2029 and March 15, 2030, respectively, subject to the terms and conditions of the applicable award agreement. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:09 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 5,765 | $150.72 | $868,900.80 |
DisclosureSEC source: 0000927066-26-000038 · wk-form4_1773778159.xml · nonDerivative · entry 4 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,905 F4 · shares: Shares withheld from issuance to satisfy tax withholding obligation in connection with the vesting of 11,836 shares, which represents 50% of the restricted stock units granted to the Reporting Person on March 15, 2023. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:09 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 33,693 | $150.72 | $5,078,208.96 |
DisclosureSEC source: 0000927066-26-000038 · wk-form4_1773778159.xml · nonDerivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,670 F3 · shares: Shares withheld from issuance to satisfy tax withholding obligations in connection with the vesting of 65,997 shares, which represents the shares received upon the satisfaction of performance criteria underlying the award of performance stock units relating to the 2023 - 2025 performance period and granted to the Reporting Person on March 15, 2023. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:09 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 3,362 | $150.72 | $506,720.64 |
DisclosureSEC source: 0000927066-26-000038 · wk-form4_1773778159.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,363 F2 · shares: Shares withheld from issuance to satisfy tax withholding obligations in connection with the vesting of 6,585 shares, which represents the shares received upon the satisfaction of performance criteria underlying the award of performance stock units relating to the 2025 performance period and granted to the Reporting Person on March 15, 2022. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:09 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 5,706 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-26-000038 · wk-form4_1773778159.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,725 F1 · shares: These restricted stock units are scheduled to vest 50% each on March 15, 2029 and March 15, 2030, respectively, subject to the terms and conditions of the applicable award agreement. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:05 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 65,997 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-26-000017 · wk-form4_1773345952.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,019 F2 · shares: Shares received upon the satisfaction of criteria underlying the award of performance stock units granted to the Reporting Person on March 15, 2023, of which 100% will vest on March 15, 2026. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:05 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 6,585 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-26-000017 · wk-form4_1773345952.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,022 F1 · shares: Shares received upon the satisfaction of criteria underlying the award of performance stock units granted to the Reporting Person on March 15, 2022, of which 100% will vest on March 15, 2026. Read SEC document |
| February 06, 2026 Filed Feb 9, 2026 23:56 UTC | DAVITA INC. DVA · Entity 3482 | Exercise / conversionStock Appreciation Rights · Derivative | 44,065 | $0.00 Strike: $108.93 | $0.00 |
DisclosureSEC source: 0000927066-26-000008 · wk-form4_1770681382.xml · derivative · entry 4 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 44,065 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Stock Appreciation Rights were granted on March 15, 2021, which vested 50% each on March 15, 2024 and March 15, 2025. Read SEC document |
| February 06, 2026 Filed Feb 9, 2026 23:56 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 5,100 | $149.22 | $761,022.00 |
DisclosureSEC source: 0000927066-26-000008 · wk-form4_1770681382.xml · nonDerivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,437 F2 · shares: Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Read SEC document |
| February 06, 2026 Filed Feb 9, 2026 23:56 UTC | DAVITA INC. DVA · Entity 3482 | Disposition to issuerCommon Stock | 32,168 | $149.22 | $4,800,108.96 |
DisclosureSEC source: 0000927066-26-000008 · wk-form4_1770681382.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,537 F1 · shares: Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Read SEC document |
| February 06, 2026 Filed Feb 9, 2026 23:56 UTC | DAVITA INC. DVA · Entity 3482 | Exercise / conversionCommon Stock | 44,065 | $108.93 | $4,800,000.45 |
DisclosureSEC source: 0000927066-26-000008 · wk-form4_1770681382.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2025 Filed Nov 7, 2025 15:26 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 21,216 | $6.80 Strike: $6.80 | $144,268.80 |
DisclosureSEC source: 0001628280-25-050467 · wk-form4_1762529216.xml · derivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,216 Underlying: Common Stock · 21,216 shares Expires 2035-11-05 F1 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively. Read SEC document |
| October 30, 2025 Filed Nov 6, 2025 16:19 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionOption to purchase Common Stock · Derivative | 94,405 | $2.10 Strike: $2.10 | $198,250.50 |
DisclosureSEC source: 0001628280-25-049954 · wk-form4_1762445975.xml · derivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 94,405 shares Expires 2025-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 70,804 options were immediately exercisable on grant date of July 19, 2016, with the remaining options vesting and available to exercise on October 31, 2016. Read SEC document |
| October 30, 2025 Filed Nov 6, 2025 16:19 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionCommon Stock | 94,405 | $2.10 | $198,250.50 |
DisclosureSEC source: 0001628280-25-049954 · wk-form4_1762445975.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,056,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 23:40 UTC | DAVITA INC. DVA · Entity 3482 | GrantStock Appreciation Rights · Derivative | 16,597 | $0.00 Strike: $143.45 | $0.00 |
DisclosureSEC source: 0000927066-25-000056 · wk-form4_1742341237.xml · derivative · entry 4 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,597 Underlying: Common Stock · 16,597 shares Expires 2030-03-15 F4 · derivative.exercise_date: The stock appreciation rights are scheduled to vest 50% each on March 15, 2028 and March 15, 2029, respectively, subject to the terms and conditions of the applicable award agreement. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 23:40 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 3,331 | $143.45 | $477,831.95 |
DisclosureSEC source: 0000927066-25-000056 · wk-form4_1742341237.xml · nonDerivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,640 F3 · shares: Shares withheld from issuance to satisfy tax withholding obligations in connection with the vesting of 7,221 shares, which represents the shares received upon the satisfaction of performance criteria underlying the award of performance stock units relating to the 2024 performance period and granted to the Reporting Person on March 15, 2022. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 23:40 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 3,093 | $143.45 | $443,690.85 |
DisclosureSEC source: 0000927066-25-000056 · wk-form4_1742341237.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,971 F2 · shares: Shares withheld from issuance to satisfy tax withholding obligations in connection with the vesting of 7,394 shares, which represents the shares received upon the satisfaction of performance criteria underlying the award of performance stock units relating to the 2024 performance period and granted to the Reporting Person on March 15, 2021. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 23:40 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 5,995 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-25-000056 · wk-form4_1742341237.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,064 F1 · shares: These restricted stock units are scheduled to vest 50% each on March 15, 2028 and March 15, 2029, respectively, subject to the terms and conditions of the applicable award agreement. Read SEC document |
| March 12, 2025 Filed Mar 14, 2025 23:56 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 7,221 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-25-000018 · wk-form4_1741996570.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,069 F2 · shares: Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on March 15, 2022, of which 100% will vest on March 15, 2025. Read SEC document |
| March 12, 2025 Filed Mar 14, 2025 23:56 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 7,394 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-25-000018 · wk-form4_1741996570.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,848 F1 · shares: Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on March 15, 2021, of which 100% will vest on March 15, 2025. Read SEC document |
| November 12, 2024 Filed Nov 18, 2024 15:59 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 43,190 | $4.64 Strike: $4.64 | $200,401.60 |
DisclosureSEC source: 0001628280-24-048193 · wk-form4_1731945585.xml · derivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,190 Underlying: Common Stock · 43,190 shares Expires 2034-11-12 F1 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on November 12, 2024, February 12, 2025, May 12, 2025 and August 12, 2025, respectively. Read SEC document |
| October 31, 2024 Filed Nov 1, 2024 13:04 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionOption to purchase Common Stock · Derivative | 16,667 | $5.43 Strike: $5.43 | $90,501.81 |
DisclosureSEC source: 0001628280-24-044663 · wk-form4_1730466270.xml · derivative · entry 4 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,667 shares Expires 2024-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 4,167 options were immediately exercisable on November 4, 2019 with the remaining options vesting and available to exercise on February 4, 2020, May 4, 2020 and August 4, 2020. Read SEC document |
| October 31, 2024 Filed Nov 1, 2024 13:04 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionOption to purchase Common Stock · Derivative | 88,470 | $2.10 Strike: $2.10 | $185,787.00 |
DisclosureSEC source: 0001628280-24-044663 · wk-form4_1730466270.xml · derivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 88,470 shares Expires 2024-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options were immediately exercisable upon grant on July 19, 2016. Read SEC document |
| October 31, 2024 Filed Nov 1, 2024 13:04 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionCommon Stock | 16,667 | $5.43 | $90,501.81 |
DisclosureSEC source: 0001628280-24-044663 · wk-form4_1730466270.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 962,134 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2024 Filed Nov 1, 2024 13:04 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionCommon Stock | 88,470 | $2.10 | $185,787.00 |
DisclosureSEC source: 0001628280-24-044663 · wk-form4_1730466270.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 945,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 22:08 UTC | DAVITA INC. DVA · Entity 3482 | Exercise / conversionStock Appreciation Rights · Derivative | 78,999 | $0.00 Strike: $75.95 | $0.00 |
DisclosureSEC source: 0000927066-24-000167 · wk-form4_1726610881.xml · derivative · entry 4 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 78,999 shares Expires 2025-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Stock Appreciation Rights were granted on March 15, 2020, which vested 50% each on March 15, 2023 and March 15, 2024. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 22:08 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 21,602 | $163.56 | $3,533,223.12 |
DisclosureSEC source: 0000927066-24-000167 · wk-form4_1726610881.xml · nonDerivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,454 F2 · shares: Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 22:08 UTC | DAVITA INC. DVA · Entity 3482 | Disposition to issuerCommon Stock | 36,684 | $163.56 | $6,000,035.04 |
DisclosureSEC source: 0000927066-24-000167 · wk-form4_1726610881.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,056 F1 · shares: Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 22:08 UTC | DAVITA INC. DVA · Entity 3482 | Exercise / conversionCommon Stock | 78,999 | $75.95 | $5,999,974.05 |
DisclosureSEC source: 0000927066-24-000167 · wk-form4_1726610881.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 28, 2024 Filed Aug 29, 2024 22:13 UTC | DAVITA INC. DVA · Entity 3482 | SaleCommon Stock | 4,740 | $155.02 | $734,784.85 |
DisclosureSEC source: 0000927066-24-000157 · wk-form4_1724969446.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,741 F2 · price: Represents the weighted average sale price of $155.0179. The range of prices for the sale of these shares was $155.00 - $155.12 rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 27, 2024 Filed Aug 29, 2024 22:13 UTC | DAVITA INC. DVA · Entity 3482 | SaleCommon Stock | 64,029 | $155.06 | $9,928,586.45 |
DisclosureSEC source: 0000927066-24-000157 · wk-form4_1724969446.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,481 F1 · price: Represents the weighted average sale price of $155.0639. The range of prices for the sale of these shares was $155.00 - $155.84 rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 23:14 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 8,064 | $136.00 | $1,096,704.00 |
DisclosureSEC source: 0000927066-24-000043 · wk-form4_1710803641.xml · nonDerivative · entry 4 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,510 F4 · shares: Shares withheld from issuance to satisfy tax withholding obligation in connection with the vesting of shares as described in footnotes 1 and 2 above. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 23:14 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 10,977 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-24-000043 · wk-form4_1710803641.xml · nonDerivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,574 F3 · shares: These restricted stock units are scheduled to vest 50% each on March 15, 2027 and March 15, 2028, subject to continued service through each applicable vesting date. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 23:14 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 1,445 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-24-000043 · wk-form4_1710803641.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,597 F2 · shares: Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on March 15, 2021, of which 100% vested on March 15, 2024. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 23:14 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 14,349 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-24-000043 · wk-form4_1710803641.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,152 F1 · shares: Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on March 15, 2020, of which 100% vested on March 15, 2024. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:04 UTC | DAVITA INC. DVA · Entity 3482 | Exercise / conversionStock Appreciation Rights · Derivative | 55,000 | $0.00 Strike: $52.41 | $0.00 |
DisclosureSEC source: 0000927066-24-000034 · wk-form4_1709935481.xml · derivative · entry 4 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 55,000 shares Expires 2024-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Stock Appreciation Rights were granted on June 20, 2019, which vested 50% each on June 20, 2022 and June 20, 2023. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:04 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 17,149 | $134.65 | $2,309,112.85 |
DisclosureSEC source: 0000927066-24-000034 · wk-form4_1709935481.xml · nonDerivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,803 F2 · shares: Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:04 UTC | DAVITA INC. DVA · Entity 3482 | Disposition to issuerCommon Stock | 21,408 | $134.65 | $2,882,587.20 |
DisclosureSEC source: 0000927066-24-000034 · wk-form4_1709935481.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,952 F1 · shares: Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:04 UTC | DAVITA INC. DVA · Entity 3482 | Exercise / conversionCommon Stock | 55,000 | $52.41 | $2,882,550.00 |
DisclosureSEC source: 0000927066-24-000034 · wk-form4_1709935481.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,360 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:43 UTC | DAVITA INC. DVA · Entity 3482 | Exercise / conversionStock Appreciation Rights · Derivative | 55,000 | $0.00 Strike: $52.41 | $0.00 |
DisclosureSEC source: 0000927066-24-000024 · wk-form4_1708728174.xml · derivative · entry 4 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2024-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Stock Appreciation Rights were granted on June 20, 2019, which vested 50% each on June 20, 2022 and June 20, 2023. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:43 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 14,930 | $123.00 | $1,836,390.00 |
DisclosureSEC source: 0000927066-24-000024 · wk-form4_1708728174.xml · nonDerivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,360 F2 · shares: Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:43 UTC | DAVITA INC. DVA · Entity 3482 | Disposition to issuerCommon Stock | 23,436 | $123.00 | $2,882,628.00 |
DisclosureSEC source: 0000927066-24-000024 · wk-form4_1708728174.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,290 F1 · shares: Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:43 UTC | DAVITA INC. DVA · Entity 3482 | Exercise / conversionCommon Stock | 55,000 | $52.41 | $2,882,550.00 |
DisclosureSEC source: 0000927066-24-000024 · wk-form4_1708728174.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2023 Filed Nov 7, 2023 16:59 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 35,750 | $5.51 Strike: $5.51 | $196,982.50 |
DisclosureSEC source: 0001628280-23-037250 · wk-form4_1699376342.xml · derivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,750 Underlying: Common Stock · 35,750 shares Expires 2033-11-03 F1 · derivative.exercise_date: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 3, 2023, February 3, 2024, May 3, 2024 and August 3, 2024, respectively. Read SEC document |
| October 17, 2023 Filed Jan 5, 2024 20:52 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionOption to purchase Common Stock · Derivative | 14,552 | $2.10 Strike: $2.10 | $30,559.20 |
DisclosureSEC source: 0001628280-24-000639 · wk-form4_1704487909.xml · derivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,552 shares Expires 2023-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options were immediately exercisable upon grant on July 19, 2016. Read SEC document |
| October 17, 2023 Filed Jan 5, 2024 20:52 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionOption to purchase Common Stock · Derivative | 100,000 | $2.10 Strike: $2.10 | $210,000.00 |
DisclosureSEC source: 0001628280-24-000639 · wk-form4_1704487909.xml · derivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2023-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 84,600 options were immediately exercisable upon grant on July 19, 2016 with the remaining options vesting on August 5, 2016 and November 5, 2016. Read SEC document |
| October 17, 2023 Filed Jan 5, 2024 20:52 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionCommon Stock | 114,552 | $2.10 | $240,559.20 |
DisclosureSEC source: 0001628280-24-000639 · wk-form4_1704487909.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 856,997 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2023 Filed May 17, 2023 21:44 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 12,861 | $96.86 | $1,245,716.46 |
DisclosureSEC source: 0000927066-23-000145 · wk-form4_1684359854.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,726 F2 · shares: Shares withheld from issuance to satisfy tax withholding obligations in connection with the vesting of 25,190 shares, which represents 50% of the shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on May 15, 2019. Read SEC document |
| May 15, 2023 Filed May 17, 2023 21:44 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 7,625 | $96.86 | $738,557.50 |
DisclosureSEC source: 0000927066-23-000145 · wk-form4_1684359854.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,587 F1 · shares: Shares withheld from issuance to satisfy tax withholding obligation in connection with the vesting of 14,935 shares, which represents 50% of the restricted stock units granted to the Reporting Person on May 15, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.